A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease
Conditions
Alzheimer's Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Clinical Trial Site, Montreal, Canada
Clinical Trial Site, Ottawa, Canada
Clinical Trial Site, Toronto, Canada
Clinical Trial Site, Toronto, Canada
Clinical Trial Site, 's-Hertogenbosch, Netherlands
Clinical Trial Site, Amsterdam, Netherlands
Clinical Trial Site, Barcelona, Spain
Clinical Trial Site, Madrid, Spain
Clinical Trial Site, Sant Cugat del Vallès, Spain
Clinical Trial Site, Glasgow, United Kingdom
Clinical Trial Site, London, United Kingdom
Clinical Trial Site, Sheffield, United Kingdom
Clinical Trial Site, Southampton, United Kingdom
Study leads
Medical Director
Study Director
Alnylam Pharmaceuticals